Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Sehsuvar Gokgoz"'
Publikováno v:
Türk Patoloji Dergisi, Vol 40, Iss 3, Pp 170-180 (2024)
Objective: The tumor microenvironment is a heterogeneous and constantly changing territory that plays an active role in tumor formation and progression. It constantly interacts with tumor cells, plays an active role in tumor development, and even app
Externí odkaz:
https://doaj.org/article/9904a487d0304f54ae3a7f02537c1d70
Autor:
Ibrahim Boga, Sebnem Ozemri Sag, Nilgun Duman, Sevda Yesim Ozdemir, Mahmut Cerkez Ergoren, Kubilay Dalci, Cem Mujde, Cem Kaan Parsak, Cagla Rencuzogullari, Ozge Sonmezler, Orcun Yalav, Adem Alemdar, Lamiya Aliyeva, Ozlem Bozkurt, Sibel Cetintas, Erdem Cubukcu, Adem Deligonul, Berkcan Dogan, Cemre Ornek Erguzeloglu, Turkkan Evrensel, Sehsuvar Gokgoz, Kazim Senol, Sahsine Tolunay, Esra Akyurek, Neslihan Basgoz, Nuriye Gökçe, Bilge Dundar, Figen Ozturk, Duygu Taskin, Mercan Demirtas, Murat Cag, Omer Diker, Polat Olgun, Sevcan Tug Bozdogan, Munis Dundar, Atil Bisgin, Sehime Gulsun Temel
Publikováno v:
European Journal of Breast Health, Vol 19, Iss 3, Pp 235-252 (2023)
Objective:Breast cancer (BC) is the most common cancer type in women and may be inherited, mostly in an autosomal dominant pattern. The clinical diagnosis of BC relies on the published diagnostic criteria, and analysis of two genes, BRCA1 and BRCA2,
Externí odkaz:
https://doaj.org/article/a71c390801df4f9498bd73b6b92a7cb8
Correlation between Ubiquitin E3 Ligases (SIAHs) and Heat Shock Protein 90 in Breast Cancer Patients
Autor:
Leila Sabour Takanlou, Gulsah Cecener, Maryam Sabour Takanlou, Hulya Ozturk Nazlioglu, Havva Tezcan Unlu, Ozgen Isik, Unal Egeli, Berrin Tunca, Erdem Cubukcu, Sahsine Tolunay, Mustafa Sehsuvar Gokgoz
Publikováno v:
Iranian Journal of Public Health, Vol 51, Iss 8 (2022)
Background: Breast cancer is a heterogeneous disease and differences in the expression levels of the ER, PR, and HER2 the triplet of established biomarkers used for clinical decision-making have been reported among breast cancer patients. Furthermore
Externí odkaz:
https://doaj.org/article/a7e0c5d247564e079a36c1c42e000b3d
Autor:
Halil Turkan, Sehsuvar Gokgoz
Publikováno v:
International Journal of Academic Medicine and Pharmacy. :1-4
Autor:
Atil Bisgin, Sebnem Ozemri Sag, Nilgun Duman, Sevda Yesim Ozdemir, Mahmut Cerkez Ergoren, Ibrahim Boga, Kubilay Dalci, Abdullah Hanta, Cem Mujde, Cem Kaan Parsak, Çagla Rencuzogullari, Ozge Sonmezler, Orcun Yalav, Adem Alemdar, Lamiya Aliyeva, Ozlem Bozkurt, Sibel Cetintas, Erdem Cubukcu, Adem Deligonul, Berkcan Dogan, Cemre Ornek Erguzeloglu, Turkkan Evrensel, Sehsuvar Gokgoz, Sahsine Tolunay, Esra Akyurek, Neslihan Basgoz, Nuriye Coşkun, Bilge Dundar, Figen Ozturk, Duygu Taskin, Mercan Demirtas, Murat Cag, Omer Diker, Polat Olgun, Sevcan Bozdogan, Munis Dundar, Sehime Gulsun Temel
BACKGROUND Breast Cancer is the most common cancer type in women, second among the all cancers, and inherited with autosomal dominant pattern. The clinical diagnosis of BC relies on the published diagnostic criteria, and two genes have been identifie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a831a3ea1cd2f0fafb1ecb83a4c63a8
https://doi.org/10.21203/rs.3.rs-1905415/v1
https://doi.org/10.21203/rs.3.rs-1905415/v1
Publikováno v:
Eur J Breast Health
Angiosarcomas of the breast are infrequent subtypes of sarcoma that are often diagnosed after radiation therapy for primary breast cancer. Primary angiosarcomas (PAS) are rare tumors that constitute 0.04% of all malignant breast tumors. We report a c
Autor:
Ismet Tasdelen, Ufuk Unal, Gamze Guney Eskiler, Erdem Cubukcu, Sibel Kahraman Çetintaş, Mustafa Sehsuvar Gokgoz, Havva Tezcan, Gulsah Cecener, Secil Ak Aksoy, Berrin Tunca, Maryam Sabour Takanlou, Unal Egeli, Turkkan Evrensel, Leila Sabour Takanlou, Isil Ezgi Eryilmaz
Publikováno v:
Cancer Genetics. 240:23-32
The aim of this study was to identify the frequency and spectrum of germline BRCA1/2 pathogenic alterations in a cohort of patients with breast carcinoma. In this study, a total of 603 breast cancer subjects from Turkey were screened for BRCA1/BRCA2
Autor:
Fuat, Aksoy, Havva, Tezcan Unlu, Gulsah, Cecener, Gamze, Guney Eskiler, Unal, Egeli, Berrin, Tunca, Ecem, Efendi Erdem, Kazım, Senol, Mustafa Sehsuvar, Gokgoz
Publikováno v:
Human heredity.
The CHEK2 gene is known to be an important signal transducer involved in DNA repair, apoptosis, or cell cycle arrest in response to DNA damage. The mutations in this gene have been associated with a wide range of cancers, both sporadic and hereditary
Autor:
Ulviyya Hasanzade, Birol Ocak, Sibel Oyucu Orhan, Adem Deligonul, Erdem Cubukcu, Sahsine Tolunay, Turkkan Evrensel, Ahmet Z. Sahin, Gorkem Yarbas, Mehmet Refik Goktug, Sibel Kahraman Çetintaş, Kazım Şenol, Zeki Burak Yanasma, Mustafa Sehsuvar Gokgoz
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports
Scientific Reports
Blood-based biomarkers reflect systemic inflammation status and have prognostic and predictive value in solid malignancies. As a recently defined biomarker, Pan-Immune-Inflammation-Value (PIV) integrates different peripheral blood cell subpopulations
Autor:
Leila, Sabour Takanlou, Gulsah, Cecener, Maryam, Sabour Takanlou, Hulya, Ozturk Nazlioglu, Havva, Tezcan Unlu, Ozgen, Isik, Unal, Egeli, Berrin, Tunca, Erdem, Cubukcu, Sahsine, Tolunay, Mustafa Sehsuvar, Gokgoz
Publikováno v:
Iranian journal of public health. 51(8)
Breast cancer is a heterogeneous disease and differences in the expression levels of the ER, PR, and HER2 the triplet of established biomarkers used for clinical decision-making have been reported among breast cancer patients. Furthermore, resistance